Amlodipine and Naproxen Interaction
Naproxen can reduce the antihypertensive effectiveness of amlodipine, though this interaction appears less pronounced with calcium channel blockers compared to other antihypertensive classes.
Mechanism of Interaction
NSAIDs like naproxen inhibit renal prostaglandin synthesis, which can lead to:
- Sodium and water retention (causing increased blood volume)
- Worsened renal function, particularly in vulnerable patients
- Blunted antihypertensive effects through interference with blood pressure regulation 1
The FDA drug label explicitly states that naproxen can reduce the antihypertensive effect of calcium channel blockers and other antihypertensive agents 1.
Clinical Significance: Calcium Channel Blockers vs Other Antihypertensives
The interaction is clinically less severe with amlodipine than with other antihypertensive classes. Multiple studies demonstrate that calcium channel blockers maintain better blood pressure control when combined with NSAIDs compared to ACE inhibitors, diuretics, or beta-blockers:
In a controlled trial of 88 hypertensive patients, amlodipine showed minimal blood pressure elevation (1.1-1.6%, p>0.290) when combined with ibuprofen or piroxicam, while lisinopril/hydrochlorothiazide showed marked increases of 7.7-9.9% (p<0.001) 2
A study of 100 patients on nicardipine found that naproxen 375mg twice daily caused <1 mmHg change in blood pressure over 4 weeks, with no significant difference from placebo 3
In 162 patients controlled on verapamil, neither naproxen nor ibuprofen caused significant blood pressure increases compared to placebo 4
Cardiovascular Risk Considerations
NSAIDs carry significant cardiovascular risks that extend beyond blood pressure effects, particularly in patients with or at risk for heart failure:
The 2017 Canadian Cardiovascular Society Guidelines provide a strong recommendation against NSAID use in heart failure patients (Strong Recommendation; High-Quality Evidence) 5. NSAIDs can:
- Cause sodium and water retention
- Worsen renal function
- Interact with ACE inhibitors/ARBs
- Increase cardiovascular events
- Precipitate heart failure decompensation
Clinical Management Algorithm
Monitor blood pressure within 1-2 weeks of initiating naproxen in patients on amlodipine:
Baseline assessment:
- Check blood pressure, renal function (creatinine/eGFR), and weight
- Assess for heart failure symptoms or history
- Evaluate volume status
If heart failure is present or suspected:
If no heart failure:
- Monitor blood pressure 1-2 weeks after starting naproxen
- Check renal function, especially if patient is elderly, volume-depleted, or has baseline renal impairment 1
- Monitor for weight gain (fluid retention)
High-risk patients requiring closer monitoring:
- Elderly patients
- Those on diuretics
- Patients with compromised renal function (eGFR <60)
- Patients on ACE inhibitors or ARBs (risk of acute renal failure) 1
Common Pitfalls
Assuming all antihypertensives interact equally with NSAIDs: Calcium channel blockers like amlodipine are significantly less affected than ACE inhibitors, diuretics, or beta-blockers 2, 4
Overlooking renal function monitoring: The combination can cause acute renal deterioration, particularly in elderly or volume-depleted patients 1
Ignoring heart failure status: NSAIDs are contraindicated in heart failure regardless of blood pressure control 5
Not considering acetaminophen as alternative: When appropriate for pain control, acetaminophen has minimal effect on blood pressure compared to NSAIDs 2
Practical Recommendations
Use the lowest effective dose of naproxen for the shortest duration necessary 6. The FDA label recommends monitoring patients taking NSAIDs concomitantly with antihypertensives for changes in blood pressure 1.
If blood pressure increases >10 mmHg systolic or diastolic:
- Consider discontinuing naproxen
- Switch to acetaminophen if appropriate for pain indication
- Adjust amlodipine dose if NSAID continuation is essential
- Re-evaluate need for ongoing NSAID therapy